Metformin and cancer mortality

The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Lev Mikhaylovich Bershteyn
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2010
Materias:
Acceso en línea:https://doaj.org/article/05da729af1a04fbb8decb7c01a66bd6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!